Amicus Therapeutics Investor Relations Material
Latest events
Q2 2025
Amicus Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Amicus Therapeutics Inc
Access all reports
Amicus Therapeutics Inc. is a biotechnology company focused on developing and commercializing treatments for rare and orphan diseases. The company specializes in therapies for lysosomal storage disorders and other genetic conditions, leveraging proprietary technologies in protein engineering and gene therapy. Amicus Therapeutics Inc. is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Amicus Therapeutics Inc
Q2 2025
Amicus Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Amicus Therapeutics Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
FOLD
Country
🇺🇸 United States